Physician

Matthew Joseph Fanelli, M.D.

According to 2025 Medicare claims, Matthew Fanelli, M.D. (NPI: 1568789279) practices dermatology in the Harrisonburg, VA market, with the plurality of this provider's patient population coming from Rockingham, VA. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1891169975; TIN: 391351587) and primary practice location at 22801-3765.

Fanelli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 982 traditional Medicare patients, billed 6,602 HCPCS/CPT codes, and received $275,962 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,242 prescription claims across 530 beneficiaries totaling $91,675 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 80 records totaling $1,604. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $216,170 and ending at $275,962. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $44,094 and ending at $91,675. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$140K$280K2015 Medicare payment: $216,170 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $280,149 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $195,285 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $66,039 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $29,937 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $95,607 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,869 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $145,252 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $228,579 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $275,962 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158514,167$216,170
20169476,058$280,149
20178424,490$195,285
20183721,582$66,039
20193021,040$29,937
20203952,322$95,607
20214693,034$122,869
20226763,195$145,252
20239145,083$228,579
20249826,602$275,962

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$123K$246K2015 Drug cost: $44,094 (USD; Tot_Drug_Cst)2016 Drug cost: $136,812 (USD; Tot_Drug_Cst)2017 Drug cost: $188,794 (USD; Tot_Drug_Cst)2018 Drug cost: $120,214 (USD; Tot_Drug_Cst)2019 Drug cost: $245,991 (USD; Tot_Drug_Cst)2020 Drug cost: $178,248 (USD; Tot_Drug_Cst)2021 Drug cost: $137,009 (USD; Tot_Drug_Cst)2022 Drug cost: $235,680 (USD; Tot_Drug_Cst)2023 Drug cost: $156,388 (USD; Tot_Drug_Cst)2024 Drug cost: $91,675 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015244597$44,094
2016289930$136,812
2017243699$188,794
2018261914$120,214
2019247736$245,991
20204541,269$178,248
20215111,392$137,009
20224971,292$235,680
20234351,018$156,388
20245301,242$91,675

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths241286$82
11102Biopsy of related skin growth, first growth351406$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more541747$61
17000Destruction of precancer skin growth, 1 growth593871$37
17003Destruction of precancer skin growth, 2-14 growths4602,805$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate1303,627$6,853
FluorouracilFluorouracil772,133$6,591
KetoconazoleKetoconazole1734,963$2,969
FluocinonideFluocinonide541,679$1,854
Doxycycline HyclateDoxycycline Hyclate1422,982$1,567

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.80$1,604ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Joseph Fanelli, M.D.?

Tedicare shows public-source Medicare data for Matthew Joseph Fanelli, M.D. (NPI 1568789279), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Joseph Fanelli, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Joseph Fanelli, M.D.?

Matthew Joseph Fanelli, M.D. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1891169975) in the available physician profile data.

Does Matthew Joseph Fanelli, M.D. have Open Payments data?

Matthew Joseph Fanelli, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.